z-logo
open-access-imgOpen Access
Preoperative administration of eculizumab to prevent surgery‐triggered hemolysis during cesarean section with paroxysmal nocturnal hemoglobinuria
Author(s) -
Li Dongping,
Wang Liangcheng,
Horiuchi Isao,
Kimura Shunichi,
Chikazawa Kenro,
Kimura Azusa,
Sasaki Shigetane,
Kuwata Tomoyuki,
Takagi Kenjiro
Publication year - 2018
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.1707
Subject(s) - paroxysmal nocturnal hemoglobinuria , eculizumab , medicine , hemoglobinuria , hemolysis , pregnancy , cesarean delivery , anesthesia , preeclampsia , surgery , complement system , immunology , antibody , biology , genetics
Key Clinical message Eculizumab in pregnancy has been reported to be effective in improving outcomes in patients with paroxysmal nocturnal hemoglobinuria. However, a cesarean section may result in surgery‐triggered hemolysis. An additional dose of eculizumab just prior to delivery is an appropriate choice to prevent postoperative hemolysis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here